Results 231 to 240 of about 5,010,243 (401)

Patient Irradiation in Diagnostic Nuclear Medicine by L. Johansson [PDF]

, 1986
James G. Kereiakes
openalex   +1 more source

Nuclear medicine imaging in idiopathic inflammatory myopathies

European Journal of Rheumatology, 2019
Thomas Nadin, Mohammed Akil, Manu Shastry, Michael Hughes   +3 more
doaj   +1 more source

Congratulations on the 60th anniversary of the Japanese Society of Nuclear Medicine. [PDF]

Ann Nucl Med
Kinuya S.
europepmc   +1 more source

Nuclear medicine and the physician [PDF]

Clinical Medicine, 2003
Peter J. Ell, HW Gray
openaire   +3 more sources

Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji, Marcello Moccia, Alessia Bianchi, Charmaine Yam, Weaam Hamed, Suraya Mohamud, Alan J. Thompson, Frederik Barkhof, Ahmed T. Toosy, Olga Ciccarelli   +9 more
wiley   +1 more source

Efficacy of clinical diagnostic procedures utilized in nuclear medicine. Nine month progress report

, 1978
Not Given Author
openalex   +1 more source

Development of lesion and organ negative cast modelling technique for quality assurance and optimization of nuclear medicine images. [PDF]

Commun Med (Lond)
Fedrigo R, Coope RJN, Chaussé G, Bloise I, Gowdy C, Bénard F, Rahmim A, Uribe CF.   +7 more
europepmc   +1 more source

Comparative Effect of Standard Versus Extended Interval Dosing of Rituximab or Ocrelizumab in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aimed to investigate the comparative effectiveness of standard versus personalized extended interval dosing of anti‐CD20 therapy on clinical and sub‐clinical outcomes in multiple sclerosis. Methods Clinical information was collected prospectively on Research Electronic Data Capture.
Nabil K. El Ayoubi, Fares Fahd, Hani Tamim, Salem Hannoun, Mark Bal, Elham El‐Hallak, Samia J. Khoury   +6 more
wiley   +1 more source

Reconstruction techniques in nuclear medicine time-of-flight PET [PDF]

, 2010
Vandenberghe, Stefaan
core   +1 more source

Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The Apolipoprotein (APOE) ε4 allele is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD); however, many ε4 carriers remain cognitively intact into old age. Leveraging plasma neuron‐derived extracellular vesicles (NDEVs), we sought to identify biomarkers of cognitive resilience and their interplay with APOE ...
Apostolos Manolopoulos, Maja Mustapic, Carlos Nogueras‐Ortiz, Francheska Delgado‐Peraza, Krishna A. Pucha, Pamela J. Yao, Joseph Blommer, Michael P. Vreones, William York, De' Larrian Knight, Stephen R. Rapp, Aladdin H. Shadyab, JoAnn E. Manson, Ramon Casanova, Robert B. Wallace, Luigi Ferrucci, Susan M. Resnick, Dimitrios Kapogiannis   +17 more
wiley   +1 more source